Core Insights - Innovation Medical (002173.SZ) reported a total revenue of 402 million yuan for the first half of 2025, with a net profit attributable to shareholders of -11.36 million yuan, an increase of 4.67 million yuan compared to the same period last year [1] Financial Performance - The company's operating cash flow showed a net inflow of 83.72 million yuan, which is an increase of 87.10 million yuan compared to the same period last year [1] - The latest debt-to-asset ratio stands at 18.03%, a decrease of 0.49 percentage points from the previous quarter [3] - The gross profit margin is reported at 12.06%, an increase of 3.10 percentage points from the previous quarter, marking two consecutive quarters of growth and a year-on-year increase of 0.27 percentage points [3] - The return on equity (ROE) is -0.64%, which is an improvement of 0.22 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is -0.03 yuan, an increase of 0.01 yuan from the same period last year [3] - The total asset turnover ratio is 0.18 times, remaining stable compared to the same period last year, with a year-on-year increase of 2.16% over three consecutive years [3] - The inventory turnover ratio is 9.84 times, an increase of 0.60 times from the same period last year, achieving two consecutive years of growth with a year-on-year increase of 6.53% [3] Shareholder Structure - The number of shareholders is reported at 82,000, with the top ten shareholders holding a total of 152 million shares, accounting for 34.46% of the total share capital [3] - The top ten shareholders and their respective holdings are as follows: - Chen Xiaying: 17.5 million shares - Chen Haijun: 5.04 million shares - Shanghai Guanghuan Technology Co., Ltd.: 4.97 million shares - Hangzhou Changjian Investment Partnership (Limited Partnership): 2.73 million shares - Han Meng: 1.02 million shares - Ma Jianjian: 0.72 million shares - Barclays Bank PLC: 0.66 million shares - Goldman Sachs International - Proprietary Funds: 0.64 million shares - Miao Ping: 0.60 million shares - Zhong Linduo: 0.49 million shares [3]
创新医疗(002173.SZ):2025年中报净利润为-1136.13万元,同比亏损减少